Partner Judith Waltz was quoted in a Compliance Cosmos article, “In Ruling That Will Shake Up How CMS Issues Guidance, Supreme Court Rejects DSH Formula,” about a U.S. Supreme Court decision throwing out a Medicare formula for calculating disproportionate share hospital (DSH) payments because it never went through formal rulemaking.
Going forward, Waltz said, there still are a lot of open issues that will need to be hashed out in the courts. “CMS will take an action and someone will go into court and say, ‘that’s an invalid action because the underlying requirement was not noticed and commented, so we can’t be held to that standard because it’s just CMS’s opinion,’” she said.
It’s also unclear what the decision means for routine guidance, Waltz said. “CMS can take the risk and say its guidance is only interpretive, but I think it will be another area of challenge,” she said.
(Subscription required.)
Going forward, Waltz said, there still are a lot of open issues that will need to be hashed out in the courts. “CMS will take an action and someone will go into court and say, ‘that’s an invalid action because the underlying requirement was not noticed and commented, so we can’t be held to that standard because it’s just CMS’s opinion,’” she said.
It’s also unclear what the decision means for routine guidance, Waltz said. “CMS can take the risk and say its guidance is only interpretive, but I think it will be another area of challenge,” she said.
(Subscription required.)
People
Related News
13 March 2024
In the News
Christopher Swift Discusses U.S. Agency Cooperation on Russian Restrictions
Foley & Lardner LLP partner Christopher Swift is quoted in the Anti-Corruption Report article, “New Russia Restrictions: Agency Cooperation and Industry Focus.”
12 March 2024
In the News
Daljit Doogal Reflects on Successful Foley-Gardere Combination
Foley & Lardner LLP Chairman and CEO Daljit Doogal is quoted in the Law360 article, “Anatomy Of Attrition: A Look At Law's Biggest Mergers.”
12 March 2024
In the News
Kyle Faget Quoted on FDA Regulation of Telehealth Advertising
Foley & Lardner LLP partner Kyle Faget is quoted in the Inside Health Policy article, “Legal Experts Contradict Califf, Say FDA Can Regulate Misleading Telehealth Ads."